SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014090
Filing Date
2023-08-09
Accepted
2023-08-09 08:00:53
Documents
66
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230630x10q.htm   iXBRL 10-Q 1022092
2 EX-31.1 tmb-20230630xex31d1.htm EX-31.1 14524
3 EX-31.2 tmb-20230630xex31d2.htm EX-31.2 14547
4 EX-32.1 tmb-20230630xex32d1.htm EX-32.1 7200
5 EX-32.2 tmb-20230630xex32d2.htm EX-32.2 7169
  Complete submission text file 0001558370-23-014090.txt   4883472

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20230630.xsd EX-101.SCH 43190
7 EX-101.CAL tmb-20230630_cal.xml EX-101.CAL 36418
8 EX-101.DEF tmb-20230630_def.xml EX-101.DEF 151313
9 EX-101.LAB tmb-20230630_lab.xml EX-101.LAB 360353
10 EX-101.PRE tmb-20230630_pre.xml EX-101.PRE 286544
60 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230630x10q_htm.xml XML 722886
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 231153428
SIC: 2834 Pharmaceutical Preparations